However, high Ki67 expression using the quantification method had a stronger association with poor outcome in those groups of patients compared to the other two methods, which suggests that the accuracy of this method to predict therapy response and confirm that high proliferative tumours showed worse outcomes and those patients should be considered for more aggressive therapy, including chemotherapy. The gene discussed is MKI67; the disease is neoplasm.